drugset / Trial / NCT07640269
Single Ascending Dose Study of ATH-097 in Healthy Participants
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Phase I, A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ATH-097 in Healthy Participants
Timeline
- Start
- 2026-07-06
- Primary completion
- 2026-10-20
- Completion
- 2026-10-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATH-097 | Unknown | — | Oral |
Indications
No indication recorded.